3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
24
Neoplasm Metastasis
10
Stomach Neoplasms
6
Pancreatic Neoplasms
4
Ovarian Neoplasms
4
Endometrial Neoplasms
4
Salivary Gland Neoplasms
3
Esophageal Neoplasms
3
Colorectal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Adenocarcinoma
3
Triple Negative Breast Neoplasms
2
Recurrence
2
Prostatic Neoplasms
2
Brain Neoplasms
2
Advanced Breast Cancer
2
Adenocarcinoma Of Esophagus
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Urethral Neoplasms
1
Unresectable Locally Recurrent Breast Cancer
1
Thyroid Neoplasms
1
Testicular Neoplasms
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Osteosarcoma
1
Interventions
tislelizumab
4
pembrolizumab
4
Injections
4
toripalimab
3
sotorasib
1
serabelisib
1
olaparib
1
nedaplatin
1
mirdametinib
1
erdafitinib
1
envafolimab
1
darolutamide
1
atezolizumab
1
adagrasib
1
abiraterone
1
Taxes
1
Nivolumab
1
Magnetic Resonance Spectroscopy
1
Fulvestrant
1
Drug Therapy
1
CD3 Complex
1
Bevacizumab
1
Antineoplastic Agents
1
Albumin-Bound Paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Advanced Solid Tumor
×
trastuzumab deruxtecan
×
90 days
×
Clear all
No trials found.